Tessa L Dagenais, LLMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 601 W Superior St, Munising, MI 49862 Phone: 906-233-1322 Fax: 906-233-1220 |
Rachel M Harmon, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 601 W Superior St, Munising, MI 49862 Phone: 906-233-1236 Fax: 906-233-1235 |
Candace L Worthington, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 622 W Superior St, Munising, MI 49862 Phone: 906-387-4721 Fax: 906-387-1750 |
Marissa Emily Ackerman, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 601 W Superior St, Munising, MI 49862 Phone: 906-387-3611 |
Mrs. Patrice Maree Evans, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 202 Elm Ave, Suite 2, Munising, MI 49862 Phone: 906-387-6404 Fax: 888-405-0628 |
News Archive
Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.
According to a study presented at the American College of Radiology annual meeting, the use of follow-up imaging is significantly less when initial emergency department ultrasound examinations are interpreted by a radiologist than a nonradiologist.
Aetna today announced that it has entered into an agreement to acquire Prodigy Health Group, the nation's largest independent third party administrator of self-funded health care plans.
On March 23, the Bakoulev Scientific Center for Cardiovascular Surgery (BSCCS) in Moscow performed Russia's first implant of the SynCardia temporary CardioWestâ„¢ Total Artificial Heart. The patient, a 60-year-old female suffering from biventricular heart failure, is the world's 850th recipient of the Total Artificial Heart.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 7 days ago